(Q34251698)

31 July 2017

title

Pharmacokinetics and tolerability of extended-release clarithromycin (English)

1 reference

31 July 2017

1 reference

1 reference

Guay DR

1

1 reference

31 July 2017

Gustavson LE

2

1 reference

31 July 2017

Devcich KJ

3

1 reference

31 July 2017

Zhang J

4

1 reference

31 July 2017

Cao G

5

1 reference

31 July 2017

Olson CA

6

1 reference

31 July 2017

publication date

1 April 2001

1 reference

31 July 2017

published in

Clinical Therapeutics

1 reference

31 July 2017

volume

23

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

566-577

1 reference

The macrolides: erythromycin, clarithromycin, and azithromycin

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980060-6

7 January 2021

Prophylaxis against disseminated Mycobacterium avium complex in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980060-6

7 January 2021

Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980060-6

7 January 2021

Overview of the tolerability profile of clarithromycin in preclinical and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980060-6

7 January 2021

Simultaneous determination of clarithromycin and 14(R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980060-6

7 January 2021

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980060-6

7 January 2021

Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980060-6

7 January 2021

Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980060-6

7 January 2021

10.1016/S0149-2918(01)80060-6

Identifiers

DOI

1 reference

31 July 2017

1 reference